一項(xiàng)評(píng)估新型乳房影像系統(tǒng)的臨床試驗(yàn)，將重點(diǎn)確定該系統(tǒng)用于早期癌癥檢查的附屬效率。

這套Sentinel乳房影像系統(tǒng)，是由美國(guó)紅外線科學(xué)集團(tuán)公司（ISA）研制開(kāi)發(fā)的，將再美國(guó)紐約Presbyterian醫(yī)院－Cornell大學(xué)Weill醫(yī)學(xué)院進(jìn)行評(píng)估。研究參與人員將會(huì)按計(jì)劃在超聲或者乳房X線成像引導(dǎo)之下，接受乳房活檢。這項(xiàng)研究將評(píng)估病理學(xué)、放射學(xué)以及乳房影像系統(tǒng)結(jié)果的相關(guān)性。

ISA公司副總裁Matthew Campisi指出：“我們十分高興能夠開(kāi)始與Cornell大學(xué)的研究，我們相信來(lái)自Sentinel系統(tǒng)的研究信息，將會(huì)證明這套系統(tǒng)能夠在對(duì)抗乳房癌的戰(zhàn)爭(zhēng)中發(fā)揮作用。Sentinel系統(tǒng)能夠?yàn)槿榉拷】敌畔⑻峁湫碌纳韺W(xué)資料，而這些資料不能從任何其它非創(chuàng)傷性檢測(cè)方法中獲得。”

Sentinel乳房掃描是一種無(wú)痛、無(wú)接觸、非創(chuàng)傷性檢查方法，適合任何年紀(jì)的女性。該技術(shù)是以尖端的數(shù)字紅外線影像技術(shù)為基礎(chǔ)的，同時(shí)聯(lián)合應(yīng)用了人工智能的高級(jí)軟件。在4分鐘的檢查之后，即可為臨床醫(yī)生提供完整詳細(xì)而客觀的報(bào)告。

這套技術(shù)將作為附屬程序，而不會(huì)替代乳房X線檢查技術(shù)或者超聲檢查方法，或者用于確定乳房整體健康狀況而單獨(dú)使用。

Breast Imaging System
 
A clinical study to evaluate a new breast imaging system will focus on determining the adjunctive effectiveness of the system for early cancer detection.

The Sentinel BreastScan imaging system, developed by Infrared Sciences Corp. (ISC; Stony Brook, NY, USA), will be assessed at the New York Presbyterian Hospital-Weill Medical College of Cornell University (New York, NY, USA). Study participants will have been scheduled to undergo a breast biopsy, either by ultrasound or mammography. The study will correlate the outcomes of pathology, radiology, and the breast imaging system.

“We are pleased and excited to commence this study with Cornell, and we believe that the information obtained from the Sentinel system will prove it to be a highly effective adjunctive tool in the war against breast cancer,” noted Matthew Campisi, vice president, ISC. “The Sentinel system provides a new physiological dimension to breast health information that is not available from any other fully noninvasive testing material.”

The Sentinel BreastScan is a painless, touchless, noninvasive technique offered to women of any age. The technology is based on sophisticated digital infrared imaging that is combined with advanced software employing artificial intelligence methods. Immediately following the four-minute test, it provides the clinician with a fully-interpreted, objective report.

The technology is intended to be an adjunctive procedure and does not replace mammography or ultrasound, or stand alone as a single test that can determine overall breast health.